MediWound Ltd (NAS:MDWD)
$ 16.65 -0.26 (-1.54%) Market Cap: 179.59 Mil Enterprise Value: 160.58 Mil PE Ratio: 0 PB Ratio: 8.67 GF Score: 56/100

Q2 2021 Mediwound Ltd Earnings Call Transcript

Aug 10, 2021 / 12:30PM GMT
Release Date Price: $26.6 (-0.78%)
Operator

Good day, and thank you for standing by. Welcome to the Q2 MediWound 2021 Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) I would now like to hand the conference over to your speaker today, Jeremy Feffer. Please go ahead.

Jeremy Feffer
LifeSci Advisors, LLC - MD

Thank you, Don, and good morning, everyone. Earlier today, MediWound issued a press release announcing financial results for the second quarter of 2021. You may access that release on the company's website under the Investors tab.

With us today are Sharon Malka, Chief Executive Officer of MediWound; and Boaz Gur-Lavie, Chief Financial Officer. Following management's prepared remarks, we will open the call for Q&A.

Before we begin, I would like to remind everyone that statements made during this call, including the Q&A session relating to MediWound's expected future performance, future business prospects or future events or plans are forward-looking statements as defined under the Private Securities

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot